4DMedical Ltd (AU:4DX) has released an update.
4DMedical Ltd has announced the successful inclusion of their CT LVAS™ technology in existing Category III CPT codes, granting it reimbursement eligibility from the U.S. Centers for Medicare & Medicaid Services for outpatient hospital procedures at a rate of US$650.50 per scan. This breakthrough ensures Medicare beneficiaries have access to 4DMedical’s advanced lung imaging technology across over 4,000 Medicare-certified hospitals, potentially influencing pricing levels for private health insurers.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.
